ART-I02 ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 46 | Malignant rheumatoid arthritis | 1 |
46. Malignant rheumatoid arthritis
Clinical trials : 4,356 / Drugs : 2,567 - (DrugBank : 415) / Drug target genes : 192 - Drug target pathways : 228
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03445715 (ClinicalTrials.gov) | January 3, 2018 | 1/2/2018 | ART-I02 in Patients With Rheumatoid Arthritis With Inflamed Wrists | A Single Dose Clinical Trial to Study the Safety of ART-I02 in Patients With Rheumatoid Arthritis | Rheumatoid Arthritis | Genetic: ART-I02 | Arthrogen | NULL | Unknown status | 18 Years | N/A | All | 15 | Phase 1 | Canada |